Computational biology and AI (artificial intelligence) are transforming how we understand and fight cancer. As cancer research generates massive volumes of data—from genomic sequences to treatment outcomes—researchers are increasingly turning to advanced math, AI, and computational methods to uncover patterns hidden in the noise.
As one example, Purdue University’s Collaborative Core for Cancer Bioinformatics, led by computational biologist Dr. Nadia Lanman, uses big data and AI-driven analysis to help scientists make sense of enormous datasets that would otherwise overwhelm traditional research methods. By applying algorithms and machine learning, Dr. Lanman’s work aids projects ranging from cellular differentiation studies to predictive cancer models.
Here is how this can help:
- Accelerate scientific discovery by detecting patterns in data that human researchers might miss.
- Support predictive models, such as digital twin simulations for cancers like bladder cancer, improving the ability to forecast disease progression.
- Enable personalized medicine approaches and facilitate interdisciplinary collaboration.
Looking toward the future, computational biology powered by AI will be essential to extract actionable insights from the growing biomedical data. These efforts promise not only to deepen our fundamental understanding of cancer but also to fuel innovations in diagnostics, therapies, and precision medicine that improve patient outcomes.